This investigation explores whether AAbs targeting D1R or D2R can effectively identify the PANDAS and potentially the PANS immunophenotypes and distinguishing a diverse patient population with infection-associated neuropsychiatric sequelae, such as OCD and/or tics, from the SC movement phenotype. The gene discussed is DRD2; the disease is Tics.